From Prof. Alfredo Rovere Guest Authorship and Ghostwriting in Publications Related to Rofecoxib. Case Study of Industry Documents From Rofecoxib Litigation. Joseph S. Ross, MD, MHS; Kevin P. Hill, MD, MHS; David S. Egilman, MD, MPH; Harlan M. Krumholz, MD, SM. MA. 2008;299(15):1800-1812. [ Abstract ] Context Authorship in biomedical publication provides recognition and establishes accountability and responsibility. Recent litigation related to rofecoxib provided a unique opportunity to examine guest authorship and ghostwriting, practices that have been suspected in biomedical publication but for which there is little documentation.
See also in the same number: Reporting Mortality Findings in Trials of Rofecoxib for Alzheimer Disease or Cognitive Impairment: A Case Study Based on Documents From Rofecoxib Litigation. JAMA. 2008;299(15):1813-1817. [ Abstract ]
Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence. DeAngelis and Fontanarosa-Editorial. JAMA 2008;299:1833-1835. [ Full text ]